NegGram

Active Ingredient(s): Nalidixic Acid
FDA Approved: * March 6, 1964
Pharm Company: * SANOFI AVENTIS US
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



NegGram Overview

Nalidixic acid (tradenames Nevigramon, Neggram, Wintomylon and WIN 18,320) is the first of the synthetic quinolone antibiotics. In a technical sense, it is a naphthyridone, not a quinolone: its ring structure is a 1,8-naphthyridine nucleus that contains two nitrogen atoms, unlike quinoline, which has a single nitrogen atom.[1] Synthetic quinolone antibiotics were discovered by George Lesher and coworkers as a byproduct of chloroquine manufacture in the 1960s.[1]...

Read more NegGram Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nalidixic_acid

Recent NegGram Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Nalidixic Acid
  • Suspension: 250mg/5ml
  • Tablet: 1g, 1gm, 250mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Nalidixic Acid or a similar ingredient: (1 result)